The Role of the Cannabis Plant in Modern Medicine

For centuries, cannabis has been used for various purposes, including reducing anxiety and pain, stimulating appetite, and treating seizures. In 2018, a medication called Epidiolex, made from purified CBD derived from cannabis, was approved for managing seizures in certain patients.

Individuals suffering from serious conditions such as schizophrenia, obsessive-compulsive disorder, Parkinson’s disease, and cancer may choose to self-medicate with cannabis because it may provide relief. 

Raphael Mechoulam, an expert in the field of chemistry, recognizes the potential benefits of cannabis for these conditions. According to him, there are numerous studies on the effects of cannabinoids on these diseases, and the majority of them have yielded positive results. He shares this insight with Knowable Magazine. 

It is important to understand the chemistry of cannabis while weighing the studies to find possible medical uses for it.

cannabis plant

The Rise of Cannabis Prohibition

After the 1910 Mexican Revolution, there was a significant influx of Mexican immigrants into the United States. It is believed that during this period, the use of recreational marijuana was popularized in the US.

During the same period, marijuana was also introduced into North America through New Orleans by West Indian immigrants and sailors from the Caribbean. In addition, jazz musicians and early marijuana supporters, such as well-known trumpeter Louis Armstrong were among the early proponents of marijuana in the 1920s and 1930s.

In the early 1900s, drugs were largely unregulated, and substances like cocaine and heroin were easily accessible, with the latter being sold as an over-the-counter medication. Cannabis, too, was available in tinctures. 

However, the passing of the Pure Food and Drug Act in 1906, which explicitly referenced cannabis indica, marked the beginning of drug regulation in the United States. In addition, the legislation mandated that drugs and food carry ingredient labels, paving the way for greater drug manufacturing and distribution transparency.


During the early stages of exploring the potential clinical uses of cannabis, Mechoulam played a vital role. He and his colleagues set out to investigate the effects of THC and CBD on epilepsy after hearing anecdotal evidence dating back to ancient times that cannabis may be able to alleviate seizures. 

Their research began with mice, and since CBD showed no toxicity or side effects, they progressed to human subjects. Then, in 1980, while still at the Hebrew University of Jerusalem, Mechoulam co-published the results from a small, 4.5-month trial of patients with epilepsy who did not respond to current medications.

The findings appeared promising, with four out of eight individuals experiencing little to no seizures throughout the study and three others noting partial improvement. Only one patient did not respond to the treatment. 

These results sparked further interest in the potential use of CBD as a treatment for epilepsy and set the stage for future research into the therapeutic benefits of cannabis.


The drug approval process is typically lengthy, but the cannabis industry faces additional challenges, such as legal barriers and difficulties in obtaining patent protections for natural compounds. This presents a significant obstacle for pharmaceutical companies as they need the ability to patent a product to justify the cost of expensive human trials and the time-consuming approval process. 

The path to approval for cannabis-based treatments has been slower than traditional pharmaceuticals. Few medicinal drugs have been licensed based on cannabinoids, and these drugs are solely based on THC and CBD. 

In addition to Epidiolex, the FDA has approved synthetic THC and a THC-like compound to combat nausea in patients undergoing chemotherapy, as well as weight loss in patients with cancer or AIDS. 

The National Institutes of Health keeps a registry of clinical trials. This includes hundreds of ongoing research projects around the world that look into the possible effects of cannabinoids on different medical conditions, such as autism, sleep disorders, Huntington’s disease, and pain management.

cannabis plant


The use of CBD (cannabidiol) in wellness marketing has steadily increased in popularity in Canada over the past few years. CBD is a non-psychoactive compound extracted from the cannabis plant, and it has been touted for its potential health benefits, including pain relief and reducing anxiety and depression.

One reason for the rise of CBD in wellness marketing is the changing public perception of cannabis. In 2018, Canada became the second country in the world to legalize recreational cannabis, which helped to destigmatize the plant and its various compounds. The Canadian government also allowed for the sale of CBD products as long as they contained less than 0.3% THC (tetrahydrocannabinol), the psychoactive compound found in cannabis that produces a “high.”

CBD has since become a buzzword in the health and wellness industry, with products such as oils, tinctures, and gummies flooding the market. In addition, many companies are now branding themselves as “CBD-infused” or “CBD-focused,” highlighting the potential benefits of using CBD in their products.

One area where CBD has particularly gained traction is in the beauty and skincare industry. Many consumers are turning to CBD-infused skincare products for their anti-inflammatory properties, which can help to calm acne-prone skin and reduce redness and irritation. CBD is also known for its antioxidant properties, which can help to protect the skin from environmental stressors and prevent signs of aging.

Another area where CBD is becoming popular is in the sports and fitness industry. Athletes are increasingly turning to CBD products for pain relief and muscle recovery, as CBD has been shown to reduce inflammation and promote healing.

It is important to note that while CBD may have potential health benefits, more research is needed to understand its effects on the body fully. Therefore, consumers should always research and consult a healthcare professional before using any new product.

The rise of CBD in wellness marketing highlights a shift towards natural and holistic approaches to health and wellness. As consumers continue seeking alternative remedies for their ailments, CBD will likely remain a popular choice.


Cancer Research provides support to researchers worldwide investigating cannabis and cannabinoids. However, the cannabis researchers’ study is generally different from that found on the street or sold in shops.

Researchers frequently employ pure versions of the chemicals they study when performing rigorous scientific studies. This approach provides more reliable evidence of the effects of different cannabinoids. 

Through numerous experiments detailed in a review article from the British Journal of Cancer, scientists have found that natural and synthetic cannabinoids have various effects on cells. Consequently, researchers are exploring whether cannabis can be a component in treating diseases such as cancer and helping to alleviate side effects.

The lack of knowledge regarding the efficacy of medicinal cannabis treatments hinders advancing the field, but it also provides a roadmap for future research.  

Researchers may be able to unlock the potential of cannabis as a therapeutic option for various diseases by concentrating on performing more rigorous investigations and clinical trials.

There is a clear demand for effective drug treatments, and the potential benefits of medicinal cannabis make it an attractive area for investigation. For instance, flower products for anxiety are a promising area for further exploration. 

The Lambert Initiative and its collaborators are poised to take on this challenge and help determine the efficacy of medicinal cannabis treatments, paving the way for a more comprehensive understanding of its potential as a medical tool. 


There are numerous complementary and alternative remedies available worldwide for managing epilepsy, ranging from gaining knowledge about the condition to using herbal remedies and spiritual healing. Some of these remedies have been studied and found to work, but others may not or even be dangerous, especially if herbal medicines are used incorrectly. 


CBD is a safe and regulated product and is likely to be the entry point for individuals who want to explore the potential benefits of THC and other health and wellness-focused adaptogens. As people become more familiar with CBD, they will be more open to trying other THC and natural remedies that can improve their overall health and wellness.

Sea to Sky Cannabis is a Vancouver-based dispensary that has been around since the early days of medicinal marijuana in 2013. Initially an alternative healing society, the medicinal dispensary has earned a reputation for offering top-notch cannabis products to those in need. 

We remain committed to providing the same high-quality service and products that our loyal customers have come to trust over the last decade.”

Sea to sky logo 3

come back again

you must be 19 to enter the website

Sea to sky logo 3

are you 19 years old?

As part of our commitment to safe and responsible consumption, you must be 19 years of age or older to enter this site. It is illegal for a person under 19 years of age to purchase or attempt to purchase cannabis. All sales are conditional on the purchaser and recipient being of legal age.